Study of Clinical Efficacy and Safety of Tosedostat in MDS

NCT02452346 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Myelodysplastic Syndrome

Interventions

DRUG: Tosedostat

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]